News

Watch CNBC's full interview with FDA Commissioner Dr. Marty Makary
FDA Commissioner Dr. Marty Makary joins 'Squawk Box' to discuss his meeting with CEOs of major pharmaceutical and biotech ...
FDA commissioner predicts ‘record’ drug approvals this year
FDA Commissioner Marty Makary said the FDA’s review process will not slow down despite layoffs at the Department of Health ...
FDA's Makary wants to increase drug access, reduce 'addictive' foods
FDA Commissioner Marty Makary spoke with Yahoo Finance about solving the food crisis, obesity crisis, and restoring trust in ...
FDA looking to make vapes less addictive as agency head claims 85% of those sold are ‘illegal’
FDA looking to make vapes less addictive as agency head claims 85% of those sold are ‘illegal’ - FDA Commissioner Marty ...
FDA Commissioner Marty Makary: Starting Process To Schedule "7-Hydroxymitragynine" Kratom Extract As Dangerous, Illegal Opioid
FDA Commissioner Marty Makary said at a press conference Tuesday that the federal government is beginning to process to ...
FDA calls for illicit drug scheduling of high-dose kratom plant extract 7-OH
The Trump administration is recommending that a compound called 7-OH be scheduled as an illicit drug, Food and Drug ...
FDA Commissioner Makary: Ban Targets Synthetic Concentrated 7-OH, Not Naturally Occurring Trace Amounts
FDA Commissioner Marty Makary said at a press conference Tuesday that scheduling "7-Hydroxymitragynine" (7-OH) kratom extract ...
KIMA-TV9h
FDA seeks to classify 7-OH as Schedule 1 drug amid addiction concerns
Food and Drug Administrator Commissioner Marty Makary has requested that the Drug Enforcement Administration classify 7-OH as ...
STAT4h
FDA names drug regulator Tidmarsh acting head of biologics center after Prasad’s exit
George Tidmarsh is taking on more responsibilities at FDA after the sudden departure of top official Vinay Prasad.
Opinion
FDA Commissioner: 100 Days of Change—Modernizing the FDA for a Healthier America | Opinion
The Food and Drug Administration (FDA) can maintain its high bar for safety and efficacy, and also cut the waste and unnecessary delays in the regulatory process.
Vinay Prasad vs the FDA: How One Doctor's Policies Collided with Politics and Cost Him His Job
Dr Vinay Prasad, the FDA's Chief Medical and Scientific Officer, resigned from his post on 29 July 2025 after mounting ...
STAT1d
How the FDA can score quick wins on transparency
Improving how the FDA disseminates already-public information about approved drugs may be unsexy, but it would be a big step ...